Table 2.
Variable | Parasympathetic model B (SE) | Sympathetic model B (SE) | Autonomic balance model B (SE) |
---|---|---|---|
Standardized predictors | |||
HF | −0.15 (0.04)** | ||
PEP | −0.008 (0.005) | ||
CAB | −0.14 (0.04)** | ||
Demographic and control variables | |||
Female | 0.51 (0.15)** | 0.40 (0.15)** | 0.41 (0.15)** |
Blacka | 0.28 (0.18) | 0.21 (0.18) | 0.28 (0.18) |
Latinoa | 0.09 (0.19) | 0.08 (0.19) | 0.06 (0.19) |
Age | 0.03 (0.02) | 0.04 (0.02)a | 0.03 (0.02) |
High school diploma | −0.13 (0.19) | −0.11 (0.19) | −0.12 (0.19) |
Current smoker | 0.30 (0.21) | 0.34 (0.21) | 0.28 (0.21) |
Ex-smoker | 0.13 (0.14) | 0.15 (0.15) | 0.15 (0.14) |
Exercise level | 0.04 (0.04) | −0.01 (0.04) | 0.03 (0.04) |
BMI (kg/m2) | 0.06 (0.01)** | 0.05 (0.01)** | 0.05 (0.01)** |
SBP (mm Hg) | −0.003 (0.003) | −0.004 (0.003) | −0.004 (0.003) |
Health conditions | −0.12 (0.13) | −0.10 (0.13) | −0.13 (0.13) |
Intercept | −0.64 (0.29)* | 0.12 (0.54) | −0.58 (0.29)* |
Study year | 0.01 (0.04) | 0.03 (0.04) | 0.02 (0.04) |
CRP C-reactive protein, HF high-frequency heart rate variability, PEP pre-ejection period, CAB cardiac autonomic balance, BMI body mass index, SBP systolic blood pressure, Health conditions presence of hypertension or diabetes or the use of cardiovascular, anti-inflammatory, anti-diabetes or sex hormone replacement medications
The reference group is Caucasian
P < 0.05,
P < 0.01